EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS101-31779 
Organism
Homo sapiens 
Tissue/cell
HT29 
Coordinate
chr3:194246580-194249530 
Target genes
Number: 10             
NameEnsembl ID
TF binding sites/motifs
Number: 51             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr3:194247698-194247716GGAAGGAAGGAAGGAAGA+10.05
EWSR1-FLI1MA0149.1chr3:194247694-194247712GGAAGGAAGGAAGGAAGG+10.83
EWSR1-FLI1MA0149.1chr3:194248749-194248767CCCGCCTTCCTTCCCTCT-6.03
EWSR1-FLI1MA0149.1chr3:194248620-194248638TCTTCCTTCTTTCTTTTC-6.05
EWSR1-FLI1MA0149.1chr3:194248608-194248626CTTCTCTTCCTTTCTTCC-6.09
EWSR1-FLI1MA0149.1chr3:194248723-194248741CCTTGCTTCCATTCTTTC-6.09
EWSR1-FLI1MA0149.1chr3:194248553-194248571ATGCCCTTCCTTCCTTCC-6.14
EWSR1-FLI1MA0149.1chr3:194247674-194247692GAAAGAAAGGAAAGAAAG+6.33
EWSR1-FLI1MA0149.1chr3:194247670-194247688GAAAGAAAGAAAGGAAAG+6.34
EWSR1-FLI1MA0149.1chr3:194248616-194248634CCTTTCTTCCTTCTTTCT-6.56
EWSR1-FLI1MA0149.1chr3:194247678-194247696GAAAGGAAAGAAAGAAGG+6.62
EWSR1-FLI1MA0149.1chr3:194248612-194248630TCTTCCTTTCTTCCTTCT-6.79
EWSR1-FLI1MA0149.1chr3:194247706-194247724GGAAGGAAGAAAGAAAGA+6.81
EWSR1-FLI1MA0149.1chr3:194248699-194248717CTTTTCTTCCTTCCTTCT-6.95
EWSR1-FLI1MA0149.1chr3:194248719-194248737CCTTCCTTGCTTCCATTC-6.98
EWSR1-FLI1MA0149.1chr3:194248565-194248583CCTTCCTCCTTCCCTTCC-7.05
EWSR1-FLI1MA0149.1chr3:194248561-194248579CCTTCCTTCCTCCTTCCC-7.08
EWSR1-FLI1MA0149.1chr3:194248711-194248729CCTTCTTTCCTTCCTTGC-7.71
EWSR1-FLI1MA0149.1chr3:194247686-194247704AGAAAGAAGGAAGGAAGG+7.85
EWSR1-FLI1MA0149.1chr3:194248557-194248575CCTTCCTTCCTTCCTCCT-7.85
EWSR1-FLI1MA0149.1chr3:194247682-194247700GGAAAGAAAGAAGGAAGG+7.87
EWSR1-FLI1MA0149.1chr3:194247702-194247720GGAAGGAAGGAAGAAAGA+8.26
EWSR1-FLI1MA0149.1chr3:194248703-194248721TCTTCCTTCCTTCTTTCC-8.52
EWSR1-FLI1MA0149.1chr3:194248715-194248733CTTTCCTTCCTTGCTTCC-8.52
EWSR1-FLI1MA0149.1chr3:194247690-194247708AGAAGGAAGGAAGGAAGG+9.09
EWSR1-FLI1MA0149.1chr3:194248707-194248725CCTTCCTTCTTTCCTTCC-9.17
Foxd3MA0041.1chr3:194249166-194249178GTTTGTTTGTTT+6.32
Foxd3MA0041.1chr3:194249170-194249182GTTTGTTTGTTT+6.32
IRF1MA0050.2chr3:194248652-194248673TCTTTCTTTCTTTTTCTTTCT+6.14
IRF1MA0050.2chr3:194247659-194247680AAAAAAAAAAAGAAAGAAAGA-6.25
IRF1MA0050.2chr3:194247719-194247740AAAGAAAAAAAGAAAGAAAGA-6.34
IRF1MA0050.2chr3:194248638-194248659TCTTTCTTTCTCTTTCTTTCT+6.76
IRF1MA0050.2chr3:194247729-194247750AGAAAGAAAGAGAAAGAAAGA-6.76
IRF1MA0050.2chr3:194247743-194247764AGAAAGAAAGAGAAAGAAAGA-6.76
ZNF263MA0528.1chr3:194248703-194248724TCTTCCTTCCTTCTTTCCTTC-6.02
ZNF263MA0528.1chr3:194248597-194248618CCTCCCCTCCCCTTCTCTTCC-6.13
ZNF263MA0528.1chr3:194248600-194248621CCCCTCCCCTTCTCTTCCTTT-6.1
ZNF263MA0528.1chr3:194248569-194248590CCTCCTTCCCTTCCCTCCCTT-6.21
ZNF263MA0528.1chr3:194248741-194248762CCTCTCCCCCCGCCTTCCTTC-6.21
ZNF263MA0528.1chr3:194248584-194248605TCCCTTCCCCTCCCCTCCCCT-6.25
ZNF263MA0528.1chr3:194248594-194248615TCCCCTCCCCTCCCCTTCTCT-6.33
ZNF263MA0528.1chr3:194248573-194248594CTTCCCTTCCCTCCCTTCCCC-6.34
ZNF263MA0528.1chr3:194247699-194247720GAAGGAAGGAAGGAAGAAAGA+6.36
ZNF263MA0528.1chr3:194248579-194248600TTCCCTCCCTTCCCCTCCCCT-6.44
ZNF263MA0528.1chr3:194248737-194248758TTTCCCTCTCCCCCCGCCTTC-6.51
ZNF263MA0528.1chr3:194248565-194248586CCTTCCTCCTTCCCTTCCCTC-6.79
ZNF263MA0528.1chr3:194248589-194248610TCCCCTCCCCTCCCCTCCCCT-6.91
ZNF263MA0528.1chr3:194247691-194247712GAAGGAAGGAAGGAAGGAAGG+6.94
ZNF263MA0528.1chr3:194247703-194247724GAAGGAAGGAAGAAAGAAAGA+6
ZNF263MA0528.1chr3:194247695-194247716GAAGGAAGGAAGGAAGGAAGA+7.03
ZNF263MA0528.1chr3:194248556-194248577CCCTTCCTTCCTTCCTCCTTC-7.79
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_45578chr3:194246668-194248716Osteoblasts
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr3194247870194248550
Number: 1             
IDChromosomeStartEnd
GH03I194526chr3194246819194249105
Enhancer Sequence
AGTGCAGTGG CGCGATCTCA GCTCACCACA ACCTCCGCCT CCCAGGTTCA AACAATTCTC 60
CTGCCTCAGC CTCCCGAGTA GCTGGGATTA CAGGCATGCA CCACCACGCC TGGCTAACTT 120
TTGTTTTTTT AGTAGAGATG GAGTTTCTCC ATGTTGGTCA GGCCAGTCTG AAACTCCTGA 180
CCTCAGGTGA TCCACCTGCC TCGGCCTCCC AAAGTGCTGG GATTATAGGC GTGAACCACT 240
GTGCCTGGCC TAGTGTACCC ATTCTTTAAG GCCCCACTCC TGTCCCTTCT CCCTACCACT 300
GTCCCTGCCT CTTACCCAAC CAGTTGTCTT TCTCTCTTGT AAACTCCAAC ATTTCACATT 360
TATCTCTTGT TATATGTGGC TAGTAACCAT TGATCACCTT CCTTATGTTT GCTCATGTTT 420
TACCTTCCCA GCTAGTCTGT ATGCTTCTCG AAGGCTAGGC TCATATTGCA CATCATTGTA 480
TCTTCTTTGC CCTCTGGAAG GCTAGGATCA TATTGCGCAT CATTGTATCT TCTTTGCCCT 540
CTGGAAGGCT AGGATCATAT TGCGCATCAT TGTATCTTCT TTGCCCCCGG AGCATGGCCT 600
GCCTAGAGGG GATATTTGGT CATTTCTTTT TCATTGATTG GTTTTATAAC CACCATAATG 660
TTTGAACTCC TTAATGTGGC CTACATGGAT TGGTCTTTGC CACCCTATTT GGCCTCATTT 720
GTGTCTCCTC CCCCTTTACA TTTTATACCT AGCCATCCTC AATACCAGCC AGTTCCTTAG 780
AAATTCCATG GGCCAAGCAC AGTGGCTCAT CACACCTGTA ATCCCAGCAC TTTGGGAGGC 840
CGAAGCGGGC GGATCACCTG AGGTCAGTAG TTCCAGACCA GCCTGACCAA CACGGTGAAA 900
CCCCATCTCT ACTAAAATAC AAAAATTAGC CAGTTGTGGT GGTGCACGCC TGTAATCCCA 960
GCTTCTCGGG AGGCTGAGGC AGGAGAATCG CTTGAACCCA GGAGGTGGGG GTTGCAGTGA 1020
GCCCAGATCG CCCTACTGCA CTCTAGCTTG GGTGACAGGG CAGTGACCCT GTCTCAAAAA 1080
AAAAAAAAAA GAAAGAAAGA AAGGAAAGAA AGAAGGAAGG AAGGAAGGAA GGAAGAAAGA 1140
AAGAAAAAAA GAAAGAAAGA GAAAGAAAGA AAGAGAAAGA AAGAAAAGAA GAAAGAAAGA 1200
AAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA AAGAAAGAAA GAAAGAAAGA 1260
AAAATTGCAG CCATGACACC TCACACAGCT TCCTCTGCCG GAACACTCAT CTCCTCTTCT 1320
GTCTGGTTGA CTCTTCTCAA CATTTGCATC TCAATCTGGG AATTACTTCC TAACGAGAAG 1380
TCTTCCCCTG GACTTCATCA GAAAGTACAA ATTAGTAAGA TTGCGCCAGC AAAATGCGTA 1440
GTGTGTGAGA AAGCACTTAG CAAGAGGAAA TGAGAAACAT TCACGTCCAC TTACTCATGA 1500
GCTTGCTCCA GCTTCTTCTT CTCCTGTCCC CTAGTTCCCT CTGGATGTCA GCCATCTGAA 1560
ATTACTCACA GGACATCTGA ATGCACTTTG TTTTATCATA CAAAGTGTGC CTTTGTACAC 1620
ACTTTTCTTC CGTTTTTTTT CTTCCTTTTT TTTTTTTTTT TGGAGGCCAA GTGCACTGAC 1680
GCCATTTCGG CTCATTGCAA CCCCTGCCTC CTGGGTTCAA GCTATTCTCC TGCCTCAGCC 1740
TCCCAAGTAG CTGGGACTAC AGGTGTGTAC CACCATGCCT GACTAATTTT TGTATTTTTA 1800
GTAGAGATGG GGTTTCACCA TGTTGGCCAG GCTGGTCTCG AACCCTGACC TCAAGTGATC 1860
CACCCACCTC GGCCTCTCAA AGTTCTGGGA TTACAGGTGT GAGCCATTAT GCCCAGCCTG 1920
TACACACTAA ACATTTTTCA TTTTTTCATT CTTCCTAGGA TTCCATTTAA TCCATGCCCT 1980
TCCTTCCTTC CTCCTTCCCT TCCCTCCCTT CCCCTCCCCT CCCCTCCCCT TCTCTTCCTT 2040
TCTTCCTTCT TTCTTTTCTC TTTCTTTCTC TTTCTTTCTT TCTTTTTCTT TCTTTCTTCT 2100
GTTCTTTCCT TCTTTTGTTC TTTTCTTCCT TCCTTCTTTC CTTCCTTGCT TCCATTCTTT 2160
CCCTCTCCCC CCGCCTTCCT TCCCTCTCTC TCCACACCCC TACCCCCGCC CTTCTCTTTC 2220
TTTTGAGAGT CTTACTCTAT TGCCCAGGAT GGAGTGCAAT GGTGCCATCA CAGCTCACTG 2280
CAACCTCTGC CTCCCGGGTT CAAGTGATCT TCGTGCCTCA GCCACCTGAG TAGCTGTGGG 2340
ATTACAAGTA TCTGCAATCA GGTCTGGCTA ATTTTTGTAT TTTTAGTAGA TATGGGGTTT 2400
CACCGTGTTG GCCAGGCTGG TCTTCAACTC CTGGCCTCAA GTGATCCACC CACCTCGGTC 2460
TCCCAAAGTG CTGGGATTAA AGGCATGAGC CACCGCGTGG CCTAATCCAT GCCCTTTCTT 2520
CACCTAATTA ACTCCTACTC ATTTTTCAAT GCCCAGCCAA GGGGTTTGTA TAATGGTGCA 2580
ATTTTTGTTT GTTTGTTTGT TTTATGAGAC GGTCTTGCTC TGTCACCCAG GCTGGAGTGC 2640
AGTGGTACGA TTTTGGCTCA CTGCAACCTC TGCCTCCCCG GGCTCAAGCA ATTCTCCTGC 2700
CTCCCTCCCG AGCAGCTGGA ATTACAAGTG CACACCACCA CACGCTGCTA ATTTTTTTGT 2760
ATTTTTAGTA GAGATAGGAT TCCACCATGT TGGCCAGGCT GATCTCGAAC TCCTGACCTC 2820
AAGTGATCTG CCTGCCTTGG CCTCCCAAAG TACTGGGATT ACAGGCATGA GCCACTGCGC 2880
TCGGCCAAAT GGGGAAAATT GTAATAATTT CTACCTCCGA GGGTTGTTGT GGGAATGAAA 2940
TGAATTAATG 2950